Literature DB >> 20131101

Non-cirrhotic extrahepatic portal vein thrombosis: a 6-year long case history.

Giorgio Ricci, Flavia Pigò, Angelo Rossi, Gianluca Bersani, Vittorio Alvisi.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20131101     DOI： 10.1007/s12185-010-0507-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  6 in total

Review 1.  Review article: portal vein thrombosis -- new insights into aetiology and management.

Authors:  G J M Webster; A K Burroughs; S M Riordan
Journal:  Aliment Pharmacol Ther       Date:  2005-01-01       Impact factor: 8.171

Review 2.  Noncirrhotic portal hypertension.

Authors:  Shiv Kumar Sarin; Ashish Kumar
Journal:  Clin Liver Dis       Date:  2006-08       Impact factor: 6.126

3.  Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

Authors:  E Joanna Baxter; Linda M Scott; Peter J Campbell; Clare East; Nasios Fourouclas; Soheila Swanton; George S Vassiliou; Anthony J Bench; Elaine M Boyd; Natasha Curtin; Mike A Scott; Wendy N Erber; Anthony R Green
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

4.  Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis.

Authors:  Massimo Primignani; Giovanni Barosi; Gaetano Bergamaschi; Umberto Gianelli; Federica Fabris; Raffaella Reati; Alessandra Dell'Era; Paolo Bucciarelli; Pier Mannuccio Mannucci
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

5.  A gain-of-function mutation of JAK2 in myeloproliferative disorders.

Authors:  Robert Kralovics; Francesco Passamonti; Andreas S Buser; Soon-Siong Teo; Ralph Tiedt; Jakob R Passweg; Andre Tichelli; Mario Cazzola; Radek C Skoda
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

6.  Undiagnosed myeloproliferative disease in cases of intra-abdominal thrombosis: the utility of the JAK2 617F mutation.

Authors:  Stephanie P'ng; Ben Carnley; Ross Baker; Nick Kontorinis; Wendy Cheng
Journal:  Clin Gastroenterol Hepatol       Date:  2008-03-07       Impact factor: 11.382
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.